These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
261 related items for PubMed ID: 12727480
1. Ex vivo and systemic transfer of adenovirus-mediated CTLA4Ig gene combined with a short course of FK506 therapy prolongs islet graft survival. Akamaru Y, Ito T, Uchikoshi F, Maeda A, Tori M, Kiyomoto T, Komoda H, Miao G, Matsuda H. Transpl Immunol; 2003; 11(1):91-100. PubMed ID: 12727480 [Abstract] [Full Text] [Related]
2. CTLA4Ig adenoviral gene transfer induces long-term islet rat allograft survival, without tolerance, after systemic but not local intragraft expression. Laumonier T, Potiron N, Boeffard F, Chagneau C, Brouard S, Guillot C, Soulillou JP, Anegon I, Le Mauff B. Hum Gene Ther; 2003 Apr 10; 14(6):561-75. PubMed ID: 12718766 [Abstract] [Full Text] [Related]
6. Long-term liver allograft survival induced by combined treatment with rAAV-hCTLA4Ig gene transfer and low-dose FK506. Yang Z, Wu X, Tsui TY, Hou Y, Luk JM, Fan ST. Transplantation; 2003 Feb 15; 75(3):303-8. PubMed ID: 12589149 [Abstract] [Full Text] [Related]
8. [Effects of gene transfer CTLA4-Ig and anti-CD154 monoclonal antibody on the rejection of rat islet xenografts]. Zhang J, Chen GH, Weng JP, Lu MQ, Yang Y, Cai CJ, Xu C, Li H. Zhonghua Wai Ke Za Zhi; 2008 Jan 15; 46(2):136-9. PubMed ID: 18509975 [Abstract] [Full Text] [Related]
11. Effects of gene transfer CTLA4Ig and anti-CD40L monoclonal antibody on islet xenograft rejection in mice. Zhang J, Li H, Jiang N, Zhang Q, Wang GS, Yi HM, Fu BS, Wang GY, Yang Y, Chen GH. Transplant Proc; 2010 Jun 15; 42(5):1835-7. PubMed ID: 20620534 [Abstract] [Full Text] [Related]
14. Transplantation of islets transduced with CTLA4-Ig and TGFbeta using adenovirus and lentivirus vectors. Fernandes JR, Duvivier-Kali VF, Keegan M, Hollister-Lock J, Omer A, Su S, Bonner-Weir S, Feng S, Lee JS, Mulligan RC, Weir GC. Transpl Immunol; 2004 Nov 15; 13(3):191-200. PubMed ID: 15381202 [Abstract] [Full Text] [Related]
17. Inhibition of rejection in murine islet xenografts by CTLA4Ig and CD40LIg gene transfer. Zhang J, Li H, Jiang N, Wang GY, Fu BS, Wang GS, Yang Y, Chen GH. Chin Med J (Engl); 2010 Nov 15; 123(21):3106-9. PubMed ID: 21162964 [Abstract] [Full Text] [Related]
18. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression. Guillot C, Mathieu P, Coathalem H, Le Mauff B, Castro MG, Tesson L, Usal C, Laumonier T, Brouard S, Soulillou JP, Lowenstein PR, Cuturi MC, Anegon I. J Immunol; 2000 May 15; 164(10):5258-68. PubMed ID: 10799887 [Abstract] [Full Text] [Related]
19. Prevention of autoimmune recurrence and rejection by adenovirus-mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat. Uchikoshi F, Yang ZD, Rostami S, Yokoi Y, Capocci P, Barker CF, Naji A. Diabetes; 1999 Mar 15; 48(3):652-7. PubMed ID: 10078573 [Abstract] [Full Text] [Related]
20. In vivo controlling of cellular response to pig islet xenografts by adenovirus-mediated expression of either membrane-bound human FasL or human decoy Fas. Kawamoto K, Tanemura M, Deguchi T, Machida T, Nishida T, Sawa Y, Doki Y, Mori M, Ito T. Transplant Proc; 2009 Mar 15; 41(1):331-3. PubMed ID: 19249549 [Abstract] [Full Text] [Related] Page: [Next] [New Search]